Novel Combined Contraceptive Estelle Among Nine New Filings At EMA

Mithra says its new oral contraceptive could be a major breakthrough in a “space where there hasn’t been any innovation in decades."

Female_Patient_Doctor
Mithra is developing a novel combined oral contraceptive • Source: Shutterstock

Estelle (estetrol/drospirenone), the novel combined oral contraceptive that Mithra is hoping will become a blockbuster product, is among nine new drugs that the European Medicines Agency has started reviewing for potential pan-EU marketing authorization.

The EMA added the contraceptive to its latest monthly list of validated marketing authorization applications (MAAs) under review. The...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Product Reviews

More from Pink Sheet